RankAlpha logo
Back to Rankings

ARGX

argenx SEC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
ARGX vs peer average
43/100
ARGX vs. peer average (C vs. C)
Grade spread
A 2 · B 4 · C 3 · D 1 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

IMVT is the first available peer comparator.

Direct development-stage FcRn comparator: Immunovant is testing IMVT-1402 in potentially registrational myasthenia gravis and CIDP studies, overlapping VYVGART's core diseases. Its Sjögren's study also makes the UNITY setback relevant to class sentiment, but ARGX's marketed franchise and IMVT's pre-commercial profile make valuation multiples non-comparable. [Immunovant update](https://www.immunovant.com/investors/news-events/press-releases/detail/83/immunovant-provides-corporate-updates-and-reports-financial)

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerIMVTImmunovant
ARGX
argenx SE
IMVT
Immunovant
Grade
C
B
Momentum
31
13
Value
59
41
Sentiment
53
87
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive

Grade position vs IMVT

ARGX / IMVT
Grade Position
Below peers
ARGX vs. peer average (C vs. C)
43/100
Momentum
31
ARGX
Value
59
ARGX
Sentiment
53
IMVT

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ARGX
1
IMVT
IMVT
B
80/100
+1
2
JNJ
JNJ
B
80/100
+1
3
UCB
UCB
B
80/100
+1
4
A
Agilent Technologies Inc Common
B
80/100
+1
5
NTRA
Natera Inc Common
D
40/100
-1
IMVT is the first peer returned for this comparison set.